The Type III Secretion Effector NleE Inhibits NF-κB Activation

English version České info

The complex host-pathogen interplay involves the recognition of the pathogen by the host's innate immune system and countermeasures taken by the pathogen. Detection of invading bacteria by the host leads to rapid activation of the transcription factor NF-κB, followed by inflammation and eradication of the intruders. In response, some pathogens, including enteropathogenic Escherichia coli (EPEC), acquired means of blocking NF-κB activation. We show that inhibition of NF-κB activation by EPEC involves the injection of NleE into the host cell. Importantly, we show that NleE inhibits NF-κB activation by preventing activation of IKKβ and consequently the degradation of the NF-κB inhibitor, IκB. This NleE activity is enhanced by, but is not dependent on, a second injected effector, NleB. In conclusion, this study describes two effectors, NleB and NleE, with no similarity to other known proteins, used by pathogens to manipulate NF-κB signaling pathways.

Vyšlo v časopise: The Type III Secretion Effector NleE Inhibits NF-κB Activation. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000743
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000743

Souhrn

Zdroje

1. DeanP

KennyB

2009 The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol 12 101 109

2. IguchiA

ThomsonNR

OguraY

SaundersD

OokaT

2009 Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191 347 354

3. DoyleSL

O'NeillLA

2006 Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72 1102 1113

4. KawaiT

AkiraS

2006 TLR signaling. Cell Death Differ 13 816 825

5. ChenZJ

2005 Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7 758 765

6. KarinM

Ben-NeriahY

2000 Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18 621 663

7. SavkovicSD

KoutsourisA

HechtG

1997 Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol 273 C1160 1167

8. HechtG

MarreroJA

DanilkovichA

MatkowskyjKA

SavkovicSD

1999 Pathogenic Escherichia coli increase Cl- secretion from intestinal epithelia by upregulating galanin-1 receptor expression. J Clin Invest 104 253 262

9. BerinMC

Darfeuille-MichaudA

EganLJ

MiyamotoY

KagnoffMF

2002 Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell Microbiol 4 635 648

10. MalladiV

PuthenedamM

WilliamsPH

BalakrishnanA

2004 Enteropathogenic Escherichia coli outer membrane proteins induce iNOS by activation of NF-kappaB and MAP kinases. Inflammation 28 345 353

11. MiyamotoY

IimuraM

KaperJB

TorresAG

KagnoffMF

2006 Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol 8 869 879

12. ZhouX

GironJA

TorresAG

CrawfordJA

NegreteE

2003 Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect Immun 71 2120 2129

13. HaufN

ChakrabortyT

2003 Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol 170 2074 2082

14. MarescaM

MillerD

QuitardS

DeanP

KennyB

2005 Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. Cell Microbiol 7 1749 1762

15. KimDW

LenzenG

PageAL

LegrainP

SansonettiPJ

2005 The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 102 14046 14051

16. HaydenMS

GhoshS

2008 Shared principles in NF-kappaB signaling. Cell 132 344 362

17. BielaszewskaM

SonntagAK

SchmidtMA

KarchH

2007 Presence of virulence and fitness gene modules of enterohemorrhagic Escherichia coli in atypical enteropathogenic Escherichia coli O26. Microbes Infect 9 891 897

18. ZurawskiDV

MumyKL

BadeaL

PrenticeJA

HartlandEL

2008 The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect Immun 76 369 379

19. MukherjeeS

KeitanyG

LiY

WangY

BallHL

2006 Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312 1211 1214

20. HaragaA

MillerSI

2003 A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun 71 4052 4058

21. KellyM

HartE

MundyR

MarchesO

WilesS

2006 Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun 74 2328 2337

22. WickhamME

LuppC

VazquezA

MascarenhasM

CoburnB

2007 Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect 9 400 407

23. DatsenkoKA

WannerBL

2000 One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97 6640 6645

24. NadlerC

ShifrinY

NovS

KobiS

RosenshineI

2006 Characterization of enteropathogenic Escherichia coli mutants that fail to disrupt host cell spreading and attachment to substratum. Infect Immun 74 839 849

25. MillsE

BaruchK

CharpentierX

KobiS

RosenshineI

2008 Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3 104 113

26. CharpentierX

OswaldE

2004 Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol 186 5486 5495